Home Cart Sign in  
Chemical Structure| 1254472-97-3 Chemical Structure| 1254472-97-3

Structure of Fezagepras sodium
CAS No.: 1254472-97-3

Chemical Structure| 1254472-97-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PBI-4050 acts as an agonist for GPR40 and as an antagonist or inverse agonist for GPR84.

Synonyms: Setogepram sodium; PBI-4050 sodium

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fezagepras sodium

CAS No. :1254472-97-3
Formula : C13H17NaO2
M.W : 228.26
SMILES Code : O=C([O-])CC1=CC=CC(CCCCC)=C1.[Na+]
Synonyms :
Setogepram sodium; PBI-4050 sodium
MDL No. :N/A

Safety of Fezagepras sodium

Related Pathways of Fezagepras sodium

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02562573 Type 2 Diabetes ... More >> Metabolic Syndrome Less << Phase 2 Completed - Canada, Alberta ... More >> Edmonton, Alberta, Canada Less <<
NCT03184584 Alstr?m Syndrome Phase 2 Phase 3 Enrolling by invitation September 2020 United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trus Birmingham, United Kingdom, B15 2PR Less <<
NCT02739217 Inflammation and Fibrosis ... More >> Diabetes Less << Phase 2 Completed - United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2PR Less <<
NCT02538536 Idiopathic Pulmonary Fibrosis ... More >>(IPF) Less << Phase 2 Completed - Canada, British Columbia ... More >> Vancouver, British Columbia, Canada Canada, Nova Scotia Halifax, Nova Scotia, Canada Canada, Ontario Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada Sherbrooke, Quebec, Canada Less <<
NCT03081598 Type 2 Diabetes Mellitus ... More >> Metabolic Syndrome Less << Phase 2 Terminated(Failure to meet rec... More >>ruitment target during the recruitment period) Less << - Canada, Alberta ... More >> C-Health Edmonton, Alberta, Canada Canada, Quebec Omnispec Clinical Research Mirabel, Quebec, Canada Canada LMC Clinical Research Inc. Barrie, Canada C-health - C-endo Division Calgary, Canada Centre de recherche clinique de Laval Laval, Canada Institut de Recherches Cliniques de Montreal (IRCM) Montréal, Canada LMC Clinical Research Inc. Montréal, Canada Manna Research Quebec City, Canada Synergy Medical Clinic Sherwood Park, Canada Manna Research Toronto, Canada Manna Research Vancouver, Canada Less <<
NCT03637049 Healthy Phase 1 Active, not recruiting September 26, 2018 United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 Less <<
NCT02955888 Cystic Fibrosis Phase 2 Terminated(Unsatisfactory rate... More >> of recruitment) Less << - Canada, British Columbia ... More >> St. Paul's Hospital - Pacific Lung Health Centre (PLHC) Vancouver, British Columbia, Canada Canada, Nova Scotia Queen Elizabeth II Health Science Center Halifax, Nova Scotia, Canada Canada, Ontario Ottawa Hospital Research Institute Ottawa, Ontario, Canada St. Michael's Hospital Toronto, Ontario, Canada Canada, Quebec Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada Canada Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval (IUCPQ) Quebec, Canada Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.38mL

0.88mL

0.44mL

21.90mL

4.38mL

2.19mL

43.81mL

8.76mL

4.38mL

 

Historical Records

Categories